Suppr超能文献

杂交手术室多模态原位再通术(MIRHOR)治疗症状性慢性颈内动脉闭塞的结果。

Outcomes of Multimodality In situ Recanalization in Hybrid Operating Room (MIRHOR) for symptomatic chronic internal carotid artery occlusions.

机构信息

Department of Vascular Neurosurgery, New Era Stroke Care and Research Institute, the PLA Rocket Force General Hospital, Beijing, China.

Department of Neurology, University of California Irvine, Irvine, California, USA.

出版信息

J Neurointerv Surg. 2019 Aug;11(8):825-832. doi: 10.1136/neurintsurg-2018-014384. Epub 2019 Jan 4.

Abstract

BACKGROUND

An in situ recanalization procedure of endovascular therapy (ET) or carotid endarterectomy (CEA) has been attempted in patients with symptomatic chronic internal carotid artery occlusions (ICAOs), though the recanalization rates of both are low.

OBJECTIVE

To investigate the outcomes of Multimodality In situ Recanalization for ICAOs in a Hybrid Operating Room (MIRHOR) at the same session.

METHODS

Symptomatic chronic ICAOs were classified into type A or B (short occlusion with or without a tapered residual root [TRR]), and C or D (long occlusion with or without TRR), and managed in a hybrid operating room with ET, CEA, or both, as needed. Primary efficacy outcome was technical success of recanalization with Thrombolysis in Myocardial Infarction 3. Secondary efficacy outcome was any stroke or death within 30 days (primary safety outcome) plus an ipsilateral ischemic stroke after 30 days.

RESULTS

Technical success was finally achieved in 35 (83.3%) of 42 consecutively enrolled patients with ICAO, which was significantly higher than 35.7% (15/42, p<0.001) from the initial ET or CEA alone. Furthermore, the success rate was in descending order: 100% (18/18) for type A and B occlusions, 75% (6/8) for type C occlusions, and 69% (11/16) for type D occlusions (p=0.017). Two secondary efficacy outcome events (5.1%) without mortality, including one (2.4%) primary safety outcome, were observed during a mean follow-up of 10.5 months.

CONCLUSION

The MIRHOR for symptomatic chronic ICAOs at the same session significantly improves technical success, with low periprocedural complications and favorable clinical outcomes. The ICAO classification appears valuable in predicting technical success.

摘要

背景

对于有症状的慢性颈内动脉闭塞(ICAO)患者,尝试了血管内治疗(ET)或颈动脉内膜切除术(CEA)的原位再通术,但两者的再通率都较低。

目的

在杂交手术室(MIRHOR)中,通过多模态原位再通治疗 ICAO(MIRHOR),探讨同一时期的治疗效果。

方法

将有症状的慢性 ICAO 分为 A 型或 B 型(短闭塞伴或不伴逐渐变细的残余根[TRR])和 C 型或 D 型(长闭塞伴或不伴 TRR),并根据需要在杂交手术室中采用 ET、CEA 或两者联合治疗。主要疗效终点是血栓溶解心肌梗死 3 级的再通技术成功。次要疗效终点是 30 天内任何卒中和死亡(主要安全性终点),以及 30 天后同侧缺血性卒中。

结果

42 例连续入组的 ICAO 患者中,最终有 35 例(83.3%)实现了技术成功,明显高于初始 ET 或 CEA 单独治疗的 35.7%(15/42,p<0.001)。此外,成功率按以下顺序递减:A 和 B 型闭塞 100%(18/18),C 型闭塞 75%(6/8),D 型闭塞 69%(11/16)(p=0.017)。在平均 10.5 个月的随访期间,观察到 2 例(5.1%)二级疗效事件(无死亡),包括 1 例(2.4%)主要安全性事件。

结论

同一时期的 MIRHOR 治疗有症状的慢性 ICAO 显著提高了技术成功率,围手术期并发症少,临床结局良好。ICAO 分类在预测技术成功率方面似乎具有价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验